News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–47
Matches
47
Sources here
7
Companies here
2
Search results Stored financial headlines

Active search

47 matching headlines

Ticker or company: TRAWMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Traws Pharma (TRAW) grants CFO Parker Nolan 90,000 stock options

Traws Pharma (TRAW) has granted its Chief Financial Officer, Parker Charles Nolan, 90,000 stock options with an exercise price of $0.68 per share. These options will vest completely on July 9, 2027, which is the first anniversary of the grant date, and will expire …

TRAW main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% · Next-week setup negative 40.7% TRAW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 4 Traws Pharma Inc For: 15 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Traws Pharma Inc on July 15th, noting that the company's stock symbol is TRAW and its price increased by 1.47%. The content primarily consists of market data, news headlines, and navigational links, typical …

TRAW main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% · Next-week setup negative 40.7% TRAW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Traws Pharma (TRAW) awards 274,000 stock options to CEO Dukes

Traws Pharma, Inc. (TRAW) has granted its CEO, Iain D. Dukes, stock options for 274,000 common shares with an exercise price of $0.68 per share. These options, awarded under the company's 2021 Incentive Compensation Plan, will vest 100% on July 9, 2027, and expire …

TRAW main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% · Next-week setup negative 40.7% TRAW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Traws Pharma (TRAW) awards 14,150 stock options to board director

Traws Pharma's director, Mary Teresa Shoemaker, was granted 14,150 stock options at an exercise price of $0.68 per share on July 9, 2026. These options, granted under the 2021 Incentive Compensation Plan, will vest 100% on their first anniversary and expire on July 9, …

TRAW main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% · Next-week setup negative 40.7% TRAW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context